MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
DataMeds AI, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$2.67+0.04 (+1.52%)
Close on Oct 19, 2026
- Market cap
- $6.87M
- P/E (TTM)
- –
- Dividend yield
- –
DataMeds AI, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacy Retail Sales [Member] | $1.59M | $1.13M | $501.16K | $172.10K | $77.76K | $114.68K | $163.66K | $144.17K | $44.54K | 89.4% | +1945.3% |
| Third Party Logistics Services [Member] | $122.73K | $199.48K | $155.41K | $203.01K | $164.51K | $80.48K | $61.55K | $45.46K | – | 6.9% | -25.4% |
| Product [Member] | $66.77K | $225.67K | $1.01M | $2.64M | $7.55M | $10.67M | $12.19M | $5.48M | – | 3.8% | -99.1% |
By region
From the segment and revenue-disaggregation notes of DataMeds AI's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.